Raia Drogasil SA
OTC:RADLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Raia Drogasil SA
OTC:RADLY
|
BR |
|
K
|
Kinross Gold Corp
LSE:0R2D
|
CA |
|
Banco Santander SA
MIL:1SANX
|
ES |
|
A
|
Attacq Ltd
JSE:ATT
|
ZA |
|
S
|
SentinelOne Inc
NYSE:S
|
US |
|
B
|
Barrick Gold Corp
F:ABR
|
CA |
|
A
|
Alcon AG
SWB:2U3
|
CH |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
New Oriental Education & Technology Group Inc
F:N1U0
|
CN |
|
N
|
Nestle India Ltd
BSE:500790
|
IN |
|
M
|
Mr Cooper Group Inc
F:07WA
|
US |
|
Flowserve Corp
NYSE:FLS
|
US |
|
D
|
DTE Energy Co
XBER:DGY
|
US |
|
W
|
Westpac Banking Corp
XBER:WBC
|
AU |
|
T
|
Takkt AG
F:TTK
|
DE |
|
M
|
MTN Group Ltd
SWB:LL6
|
ZA |
|
3i Group PLC
F:IGQ
|
UK |
|
Hitachi Ltd
F:HIA1
|
JP |
|
Avista Corp
NYSE:AVA
|
US |
|
K
|
Konami Holdings Corp
OTC:KONMY
|
JP |
|
K
|
Kirin Holdings Co Ltd
XBER:KIR
|
JP |
|
U
|
US Bancorp
DUS:UB5
|
US |
Raia Drogasil SA
Raia Drogasil is one of Brazil’s largest pharmacy chains. It sells prescription medicines, over-the-counter drugs, health and personal care products, beauty items, and everyday convenience goods through its stores and online channels. Its main customers are ordinary consumers who need to fill prescriptions, buy treatments for common ailments, or pick up routine household and personal care items. The company makes money mainly by selling products at retail prices. In practice, that means it earns from a steady stream of repeat purchases rather than from big one-time sales. Its pharmacies also act as local health access points, which helps it build frequent customer visits and handle regulated medicine sales, a core part of the business. What makes Raia Drogasil different is its role in a tightly regulated, essential retail market. Pharmacies need broad product availability, reliable supply chains, and strong store coverage in places where people live and work. That gives the company a mix of convenience retail and healthcare distribution, with revenue tied to everyday consumer needs rather than discretionary spending.
Raia Drogasil is one of Brazil’s largest pharmacy chains. It sells prescription medicines, over-the-counter drugs, health and personal care products, beauty items, and everyday convenience goods through its stores and online channels. Its main customers are ordinary consumers who need to fill prescriptions, buy treatments for common ailments, or pick up routine household and personal care items.
The company makes money mainly by selling products at retail prices. In practice, that means it earns from a steady stream of repeat purchases rather than from big one-time sales. Its pharmacies also act as local health access points, which helps it build frequent customer visits and handle regulated medicine sales, a core part of the business.
What makes Raia Drogasil different is its role in a tightly regulated, essential retail market. Pharmacies need broad product availability, reliable supply chains, and strong store coverage in places where people live and work. That gives the company a mix of convenience retail and healthcare distribution, with revenue tied to everyday consumer needs rather than discretionary spending.
Top line: Excluding 4Bio, gross revenue reached BRL 12 billion, up 20% year over year, with mature-store sales up 12.8% and digital revenue up 66%.
Profitability: EBITDA came in at BRL 821 million, up about 32%, while net income rose to BRL 299.8 million, up 70%.
Market share: Management said the company gained 150 bps of nationwide market share, with especially strong gains in São Paulo.
Digital strength: Digital channels accounted for about 30% of sales and the app remained the main driver, with 83% of digital sales.
GLP-1 outlook: Management said GLP-1 availability should improve from April onward, with generics likely to lower average prices but support broader access and long-term penetration.
Costs and cash: The cash cycle improved by 10 days, driven mainly by lower inventory, while selling expenses and G&A continued to be well controlled.
4Bio: The 4Bio sale closed and the business is now treated as a discontinued operation in the reported results.
